您的位置: 首页 > 农业专利 > 详情页

LIJEÄŚENJE MULTIPLE SKLEROZE LAKVINIMODOM
专利权人:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人:
TARCIC, NORA,BAR-ZOHAR, DAN,KOFLER, DINA
申请号:
HRP20150988
公开号:
HRP20150988T1
申请日:
2015.09.18
申请国别(地区):
HR
年份:
2015
代理人:
摘要:
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充